Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Stage 1 - Interim Analysis Population	STARTED	Ewing Sarcoma	23
Stage 1 - Interim Analysis Population	STARTED	Osteosarcoma	22
Stage 1 - Interim Analysis Population	COMPLETED	Ewing Sarcoma	21
Stage 1 - Interim Analysis Population	COMPLETED	Osteosarcoma	21
Stage 1 - Interim Analysis Population	NOT COMPLETED	Ewing Sarcoma	2
Stage 1 - Interim Analysis Population	NOT COMPLETED	Osteosarcoma	1
Stage 2 - Final Analysis Population	STARTED	Ewing Sarcoma	45
Stage 2 - Final Analysis Population	STARTED	Osteosarcoma	45
Stage 2 - Final Analysis Population	COMPLETED	Ewing Sarcoma	39
Stage 2 - Final Analysis Population	COMPLETED	Osteosarcoma	42
Stage 2 - Final Analysis Population	NOT COMPLETED	Ewing Sarcoma	6
Stage 2 - Final Analysis Population	NOT COMPLETED	Osteosarcoma	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02243605/flow